Boditech Med Executive and Leadership Team

Yule Choi, the Chief Executive Officer at Boditech Med, directs the overarching corporate strategy and global market expansion initiatives. The Chief Executive Officer manages the alignment of diagnostic product portfolios with international healthcare standards, ensuring that point-of-care testing solutions reach diverse clinical environments. By overseeing the integration of capillary and venous blood testing technologies, Yule Choi drives the company toward sustained growth in the competitive in-vitro diagnostics sector. This leadership role involves constant collaboration with the Board to refine operational efficiency and maximize shareholder value across the KOSDAQ-listed entity. Through the implementation of rigorous quality control protocols, the Chief Executive Officer maintains the reputation of the firm as a reliable partner for medical professionals worldwide. Yule Choi prioritizes the scaling of manufacturing capabilities to meet the rising demand for rapid diagnostic tools, ultimately securing the long-term financial health and market influence of the organization.

Eui-Yul Choi, the Co-Founder & Chief Executive Officer at Boditech Med, architects the long-term vision for diagnostic innovation and clinical research. The Co-Founder & Chief Executive Officer focuses on the development of new biomarkers, ensuring that the product pipeline addresses the most pressing needs of modern healthcare systems. By guiding the research teams, Eui-Yul Choi fosters an environment of scientific discovery that translates complex biological data into actionable clinical insights. This executive role requires balancing immediate product performance with the pursuit of future diagnostic breakthroughs that enhance patient quality of life. Through the oversight of international partnerships, the Co-Founder & Chief Executive Officer expands the reach of the company into emerging markets, solidifying the global footprint of the brand. Eui-Yul Choi maintains a deep commitment to technical excellence, ensuring that every diagnostic solution meets the highest standards of accuracy and reliability for clinicians operating in diverse medical settings.

Euiyul Choi, the Founder & Chief Executive Officer at Boditech Med, leads the strategic mission to revolutionize point-of-care testing through continuous technological evolution. The Founder & Chief Executive Officer manages the organizational culture, emphasizing the importance of precision and accessibility in diagnostic medicine. By directing the expansion of the biomarker portfolio, Euiyul Choi ensures that the company remains at the forefront of the in-vitro diagnostics industry. This leadership position involves navigating complex regulatory landscapes to facilitate the global distribution of testing solutions. Through the cultivation of internal talent and the promotion of collaborative research, the Founder & Chief Executive Officer drives the development of innovative tools that support clinicians in 120 countries. Euiyul Choi oversees the implementation of sustainable business practices that align with the long-term goals of the firm, ensuring that the company continues to provide essential health data to patients and medical providers across the globe.

Keith Nahm, the Chief Technology Officer at Boditech Med, directs the engineering and technical infrastructure required to produce high-performance diagnostic equipment. The Chief Technology Officer oversees the integration of advanced hardware and software systems that power the company's point-of-care testing platforms. By managing the technical roadmap, Keith Nahm ensures that all diagnostic solutions maintain superior sensitivity and speed for clinical applications. This role involves close coordination with research departments to translate scientific concepts into scalable, market-ready products. Through the optimization of manufacturing processes, the Chief Technology Officer enhances production efficiency and product consistency across the global supply chain. Keith Nahm leads the technical teams in identifying emerging trends in medical technology, allowing the firm to adapt quickly to the evolving requirements of the healthcare sector. By maintaining a focus on technical reliability, the Chief Technology Officer supports the overall mission of delivering accurate health data to clinicians and patients everywhere.